These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 34755040)

  • 1. Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: COVID-19 Vaccines-Biology, Current Evidence and Recommendations.
    Murthy SK; Kuenzig ME; Windsor JW; Ghia JE; Griffiths AM; Panaccione R; Seow CH; Benchimol EI; Bernstein CN; Bitton A; Huang JG; Jones JL; Lee K; Kaplan GG; Mukhtar MS; Tandon P; Targownik LE; Gibson DL
    J Can Assoc Gastroenterol; 2021 Dec; 4(Suppl 2):S54-S60. PubMed ID: 34755040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Executive Summary.
    Ellen Kuenzig M; Windsor JW; Barrett L; Bernstein CN; Bitton A; Carroll MW; Chauhan U; Coward S; Fowler S; Ghia JE; Geist R; Gibson DL; Graff LA; Griffiths AM; Guoxian Huang J; Jones JL; Khanna R; Lakatos PL; Lee K; Mack DR; Marshall JK; Mukhtar MS; Murthy SK; Nguyen GC; Panaccione R; Seow CH; Singh H; Tandon P; Targownik LE; Zelinsky S; Benchimol EI; Kaplan GG
    J Can Assoc Gastroenterol; 2021 Dec; 4(Suppl 2):S1-S9. PubMed ID: 34755033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risks of SARS-CoV-2 Infection and Immune Response to COVID-19 Vaccines in Patients With Inflammatory Bowel Disease: Current Evidence.
    Esposito S; Caminiti C; Giordano R; Argentiero A; Ramundo G; Principi N
    Front Immunol; 2022; 13():933774. PubMed ID: 35812420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody Response to SARS-CoV-2 Vaccination in Patients with Inflammatory Bowel Disease: Results of a Single-Center Cohort Study in a Tertiary Hospital in Germany.
    Classen JM; Muzalyova A; Nagl S; Fleischmann C; Ebigbo A; Römmele C; Messmann H; Schnoy E
    Dig Dis; 2022; 40(6):719-727. PubMed ID: 34915480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in clinical practice: management of inflammatory bowel disease during the COVID-19 pandemic.
    Lin S; Lau LH; Chanchlani N; Kennedy NA; Ng SC
    Gut; 2022 Jul; 71(7):1426-1439. PubMed ID: 35477864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crohn's and Colitis Canada's 2021 Impact of COVID-19 & Inflammatory Bowel Disease in Canada: A Knowledge Translation Strategy.
    Kaplan GG; Windsor JW; Crain J; Barrett L; Bernstein CN; Bitton A; Chauhan U; Coward S; Fowler S; Ghia JE; Gibson DL; Griffiths AM; Jones JL; Khanna R; Kuenzig ME; Lakatos PL; Lee K; Mack DR; Marshall JK; Mawani M; Murthy SK; Panaccione R; Seow CH; Targownik LE; Zelinsky S; Benchimol EI
    J Can Assoc Gastroenterol; 2021 Dec; 4(Suppl 2):S10-S19. PubMed ID: 34755034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 Vaccination Among Individuals With Inflammatory Bowel Disease: Perception, Efficacy, and Safety.
    Weaver KN; Kappelman MD; Long MD
    Gastroenterol Hepatol (N Y); 2022 Jul; 18(7):388-399. PubMed ID: 36397773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Seniors With IBD.
    Bernstein CN; Singh H; Murthy SK; Nguyen GC; Benchimol EI; Bitton A; Kuenzig ME; Huang JG; Jones JL; Lee K; Targownik LE; Windsor JW; Mukhtar MS; Tandon P; Kaplan GG
    J Can Assoc Gastroenterol; 2021 Dec; 4(Suppl 2):S34-S39. PubMed ID: 34755037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 2023 Impact of Inflammatory Bowel Disease in Canada: COVID-19 and IBD.
    Kaplan GG; Kuenzig ME; Windsor JW; Bernstein CN; Bitton A; Coward S; Jones JL; Lee K; Murthy SK; Targownik LE; Peña-Sánchez JN; Ghandeharian S; Rohatinsky N; Weinstein J; Jones May T; Browne M; Jannati N; Tabatabavakili S; Im JHB; Meka S; Vukovic S; Davis T; Goddard Q; Gorospe J; Stocks T; Caplan L; Kanaan N; Stuart D; Ramsay T; Robinson KJ; Charron-Bishop D; Benchimol EI
    J Can Assoc Gastroenterol; 2023 Sep; 6(Suppl 2):S76-S82. PubMed ID: 37674494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Children and Expectant Mothers With Inflammatory Bowel Disease.
    Benchimol EI; Carroll MW; Geist R; Griffiths AM; Huang JG; Mack DR; Bernstein CN; Bitton A; Jones JL; Kaplan GG; Kuenzig ME; Lee K; Mukhtar MS; Murthy SK; Tandon P; Targownik LE; Windsor JW; Seow CH
    J Can Assoc Gastroenterol; 2021 Dec; 4(Suppl 2):S27-S33. PubMed ID: 34755036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination against SARS-CoV-2 in Patients with Inflammatory Bowel Diseases: Where Do We Stand?
    Tepasse PR; Vollenberg R; Nowacki TM
    Life (Basel); 2021 Nov; 11(11):. PubMed ID: 34833096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation and Short-term Adverse Events of Anti-SARS-CoV-2 Vaccines in Inflammatory Bowel Disease Patients: An International Web-based Survey.
    Ellul P; Revés J; Abreu B; Chaparro M; Gisbert JP; Allocca M; Fiorino G; Barberio B; Zingone F; Pisani A; Cassar D; Michalopoulos G; Mantzaris G; Koutroubakis I; Karmiris K; Katsanos K; Ďuricova D; Burisch J; Madsen GR; Maaser C; Naila A; Orfanoudaki E; Milivojevic V; Buisson A; Avedano L; Leone S; Torres J
    J Crohns Colitis; 2022 Aug; 16(7):1070-1078. PubMed ID: 35037033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 vaccination in patients with inflammatory bowel disease.
    Prentice RE; Rentsch C; Al-Ani AH; Zhang E; Johnson D; Halliday J; Bryant R; Begun J; Ward MG; Lewindon PJ; Connor SJ; Ghaly S; Christensen B
    GastroHep; 2021 Jul; 3(4):212-228. PubMed ID: 34539248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Mental Health and Quality of Life.
    Graff LA; Fowler S; Jones JL; Benchimol EI; Bitton A; Huang JG; Kuenzig ME; Kaplan GG; Lee K; Mukhtar MS; Tandon P; Targownik LE; Windsor JW; Bernstein CN
    J Can Assoc Gastroenterol; 2021 Dec; 4(Suppl 2):S46-S53. PubMed ID: 34755039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review Article: vaccination for patients with inflammatory bowel disease during the COVID-19 pandemic.
    Doherty J; Fennessy S; Stack R; O' Morain N; Cullen G; Ryan EJ; De Gascun C; Doherty GA
    Aliment Pharmacol Ther; 2021 Nov; 54(9):1110-1123. PubMed ID: 34472643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 Vaccine Hesitancy among Patients with Inflammatory Bowel Disease Receiving Biologic Therapies in Kuwait: A Cross-Sectional Study.
    Shehab M; Zurba Y; Al Abdulsalam A; Alfadhli A; Elouali S
    Vaccines (Basel); 2021 Dec; 10(1):. PubMed ID: 35062716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 vaccination in adults with inflammatory bowel disease.
    Lutz M; Lazarus S; Caldera F
    Therap Adv Gastroenterol; 2023; 16():17562848231173130. PubMed ID: 37234702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine Acceptance in Patients with Inflammatory Bowel Disease: Lessons Learned from the COVID-19 Pandemic.
    Mastrangeli G; Vernia F; Necozione S; Muselli M; Frassino S; Cesaro N; Latella G; Fabiani L
    Vaccines (Basel); 2024 May; 12(5):. PubMed ID: 38793802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 Vaccination in Inflammatory Bowel Disease (IBD).
    Kubas A; Malecka-Wojciesko E
    J Clin Med; 2022 May; 11(9):. PubMed ID: 35566802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.